Project Details
Description
An Interventional, Multicenter, Single Arm, Phase I/IIA Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-EB on Epidermolysis Bullosa (EB)
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/19 → 6/30/24 |
Funding
- RHEACELL GMBH & CO KG
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.